SUMATRIPTAN

被引：49

作者：

BATEMAN, DN

机构：

[1] Regional Drug and Therapeutics Centre, Wolfson Unit, Newcastle upon Tyne, NE1 4LP, Claremont Place

来源：

LANCET | 1993年 / 341卷 / 8839期

关键词：

D O I：

10.1016/0140-6736(93)90079-V

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：221 / 224

页数：4

共 23 条

[1] MIGRAINE - THEORIES OF PATHOGENESIS [J].

BLAU, JN .

LANCET, 1992, 339 (8803) :1202-1207

[2]

BROWN EG, 1991, EUR NEUROL, V31, P399

[3] EVIDENCE FOR 5-HT1B 1D RECEPTORS MEDIATING THE ANTIMIGRAINE EFFECT OF SUMATRIPTAN AND DIHYDROERGOTAMINE [J].

BUZZI, MG ;

MOSKOWITZ, MA .

CEPHALALGIA, 1991, 11 (04) :165-168

[4] CARDIORESPIRATORY DISTRESS AFTER SUMATRIPTAN GIVEN BY INJECTION [J].

CURTIN, T ;

BROOKS, AP ;

ROBERTS, JA .

BRITISH MEDICAL JOURNAL, 1992, 305 (6855) :713-714

[5] ORAL SUMATRIPTAN IN PHARMACOKINETICS IN THE MIGRAINOUS STATE [J].

CUTLER, NR ;

HUSSEY, EK ;

SRAMEK, JJ ;

CLEMENTS, BD ;

PAULSGROVE, LA ;

BUSCH, MA ;

DONN, KH .

CEPHALALGIA, 1991, 11 :222-223

[6] SUMATRIPTAN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN THE ACUTE TREATMENT OF MIGRAINE AND CLUSTER HEADACHE [J].

DECHANT, KL ;

CLISSOLD, SP .

DRUGS, 1992, 43 (05) :776-798

[7]

DENBOER MO, 1991, BRIT J PHARMACOL, V102, P323

[8]

EDVINSSON L, 1989, CEPHALALGIA S10, V9, P39

[9] THE CLINICAL-PHARMACOLOGY, PHARMACOKINETICS AND METABOLISM OF SUMATRIPTAN [J].

FOWLER, PA ;

LACEY, LF ;

THOMAS, M ;

KEENE, ON ;

TANNER, RJN ;

BABER, NS .

EUROPEAN NEUROLOGY, 1991, 31 (05) :291-294

[10] MIGRAINE PAIN ASSOCIATED WITH MIDDLE CEREBRAL-ARTERY DILATATION - REVERSAL BY SUMATRIPTAN [J].

FRIBERG, L ;

OLESEN, J ;

IVERSEN, HK ;

SPERLING, B .

LANCET, 1991, 338 (8758) :13-17

← 1 2 3 →